Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data

<b>Background/Objectives</b>: During the COVID-19 pandemic, several antivirals were approved or repurposed, but their safety profiles have not been fully compared. Pharmacovigilance data help clarify how these drugs perform in real-world use. <b>Methods</b>: This study performed a comparative pharma...

詳細記述

書誌詳細

主要な著者:	Paul Andrei Negru, Delia Mirela Tit, Andrei Flavius Radu, Gabriela Bungau, Raluca Anca Corb Aron, Ruxandra Cristina Marin
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2025-06-01
シリーズ:	Biomedicines
主題:	COVID-19 antivirals EudraVigilance pharmacovigilance system organ class individual case safety reports
オンライン･アクセス:	https://www.mdpi.com/2227-9059/13/6/1387
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!